Here's How Jakafi's Patent Expiry Impacts Incyte Corporation's (INCY) Growth Prospects

Here's How Jakafi's Patent Expiry Impacts Incyte Corporation's (INCY) Growth Prospects

Incyte Corporation is preparing for Jakafi's patent expiry in 2028, focusing on growth beyond that period. With innovative therapies and a diverse product pipeline, including Opzelura and other promising candidates, the company aims to mitigate the impact of the patent expiry.

Read More

Did you find this insightful?